Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Thong MSY, Koch-Gallenkamp L, Jansen L, Bertram H, Eberle A, Holleczek B, Waldeyer-Sauerland M, Waldmann A, Zeissig SR, Brenner H, Arndt V. Age-specific health-related quality of life in long-term and very long-term colorectal cancer survivors versus population controls - a population-based study^{. Acta Oncol 2019;58:801-810. [PMID: 30736716 DOI: 10.1080/0284186x.2018.1557340] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]}

For:	Thong MSY, Koch-Gallenkamp L, Jansen L, Bertram H, Eberle A, Holleczek B, Waldeyer-Sauerland M, Waldmann A, Zeissig SR, Brenner H, Arndt V. Age-specific health-related quality of life in long-term and very long-term colorectal cancer survivors versus population controls - a population-based study^{. Acta Oncol 2019;58:801-810. [PMID: 30736716 DOI: 10.1080/0284186x.2018.1557340] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]}

Number

Cited by Other Article(s)

Dığrak E, Akkoç I. The mediating role of COVID-19 anxiety on the relationship between quality of life and spiritual well-being, and hopelessness: A study on cancer patients. Palliat Support Care 2024:1-10. [PMID: 39508086 DOI: 10.1017/s1478951524001238] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2024]

Pennings AJ, Vink GR, van Kuijk S, Melenhorst J, Beets GL, May AM, Breukink SO. Quality of life and functional outcome of rectal cancer patients: A prospective cohort study. Colorectal Dis 2024;26:1892-1902. [PMID: 39358881 DOI: 10.1111/codi.17181] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/24/2024] [Revised: 08/07/2024] [Accepted: 08/27/2024] [Indexed: 10/04/2024]

Springer F, Matsuoka A, Obama K, Mehnert-Theuerkauf A, Uchitomi Y, Fujimori M. Identifying central dimensions of quality of life including life-related values, preferences and functional health in older patients with cancer: a scoping review protocol. Front Psychol 2024;15:1455825. [PMID: 39502146 PMCID: PMC11534725 DOI: 10.3389/fpsyg.2024.1455825] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/27/2024] [Accepted: 10/08/2024] [Indexed: 11/08/2024] Open

Abstract

Background

Older patients with cancer already represent the largest proportion of cancer survivors which will further increase in the upcoming years. However, older patients are highly underrepresented in clinical research, leading to a detrimental knowledge gap. Research on important aspects of quality of life (QoL) and associated factors for older patients with cancer is insufficient to date.

Aim

The objective of this scoping review therefore is to investigate the dimensions of QoL including functional health, life-relevant values and preferences in older adults with cancer across all tumor entities and health care settings. It will further identify medical, sociodemographic, psychosocial and geriatric aspects associated with QoL in the elderly and compare these with younger cancer patients and older non-cancer cases.

Methods

Published articles investigating QoL dimensions and associated factors in older patients with cancer, i.e., exclusively patients ≥65 years or mean/median age ≥ 70 years for age-mixed samples, or that compare results of older with younger cancer patients or with older non-cancer cases will be considered for this scoping review. Older patients with cancer across all tumor entities, disease stages and health care setting will be included. PubMed and PsychINFO databases will be searched for relevant articles. Abstracts and titles will be screened for basic inclusion, and two independent reviewers will conduct a full text screening to evaluate the age criteria and decide on the final inclusion of the study. Data on study and participant characteristics, QoL dimensions and geriatric factors will be extracted using a data extraction sheet. Results will be summarized descriptively to address the objectives of this review.

Discussion

The findings of this scoping review will provide valuable insights into central dimensions of QoL, including values, preferences and functional health in older adults with cancer, and help to improve targeted interventions and healthcare planning.

Collapse

Marcos-Delgado A, Martín-Sánchez V, Molina-Barceló A, Alonso-Molero J, Pérez-Gómez B, Pollán M, Aragonés N, Ederra-Sanza M, Fernández-Tardón G, Binefa G, Moreno V, Barrios-Rodríguez R, Amiano P, Huerta JM, Teso EP, Alguacil J, Castaño-Vinyals G, Kogevinas M, Molina de la Torre AJ. Health-Related Quality of Life in Long-Term Colorectal Cancer Survivors. Healthcare (Basel) 2024;12:1917. [PMID: 39408097 PMCID: PMC11475455 DOI: 10.3390/healthcare12191917] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/18/2024] [Revised: 09/10/2024] [Accepted: 09/18/2024] [Indexed: 10/20/2024] Open

Affiliation(s)

Alba Marcos-Delgado The Research Group in Gene-Environment and Health Interactions, Institute of Biomedicine (IBIOMED), Universidad de León, 24071 León, Spain; (V.M.-S.); (A.J.M.d.l.T.) Department of Biomedical Sciences, Area of Preventive Medicine and Public Health, Universidad de León, 24071 León, Spain CIBER Epidemiology and Public Health CIBERESP, 28029 Madrid, Spain; (J.A.-M.); (B.P.-G.); (M.P.); (N.A.); (M.E.-S.); (G.F.-T.); (G.B.); (V.M.); (R.B.-R.); (P.A.); (J.M.H.); (J.A.); (G.C.-V.); (M.K.)
Vicente Martín-Sánchez The Research Group in Gene-Environment and Health Interactions, Institute of Biomedicine (IBIOMED), Universidad de León, 24071 León, Spain; (V.M.-S.); (A.J.M.d.l.T.) Department of Biomedical Sciences, Area of Preventive Medicine and Public Health, Universidad de León, 24071 León, Spain CIBER Epidemiology and Public Health CIBERESP, 28029 Madrid, Spain; (J.A.-M.); (B.P.-G.); (M.P.); (N.A.); (M.E.-S.); (G.F.-T.); (G.B.); (V.M.); (R.B.-R.); (P.A.); (J.M.H.); (J.A.); (G.C.-V.); (M.K.)
Ana Molina-Barceló Cancer and Public Health Area, FISABIO-Public Health, 46022 Valencia, Spain;
Jessica Alonso-Molero CIBER Epidemiology and Public Health CIBERESP, 28029 Madrid, Spain; (J.A.-M.); (B.P.-G.); (M.P.); (N.A.); (M.E.-S.); (G.F.-T.); (G.B.); (V.M.); (R.B.-R.); (P.A.); (J.M.H.); (J.A.); (G.C.-V.); (M.K.) Department of Preventive Medicine and Public Health, IDIVAL, Universidad de Cantabria, 39005 Cantabria, Spain
Beatriz Pérez-Gómez CIBER Epidemiology and Public Health CIBERESP, 28029 Madrid, Spain; (J.A.-M.); (B.P.-G.); (M.P.); (N.A.); (M.E.-S.); (G.F.-T.); (G.B.); (V.M.); (R.B.-R.); (P.A.); (J.M.H.); (J.A.); (G.C.-V.); (M.K.) Department of Epidemiology of Chronic Diseases, National Center for Epidemiology, Carlos III Institute of Health, 28029 Madrid, Spain
Marina Pollán CIBER Epidemiology and Public Health CIBERESP, 28029 Madrid, Spain; (J.A.-M.); (B.P.-G.); (M.P.); (N.A.); (M.E.-S.); (G.F.-T.); (G.B.); (V.M.); (R.B.-R.); (P.A.); (J.M.H.); (J.A.); (G.C.-V.); (M.K.) Department of Epidemiology of Chronic Diseases, National Center for Epidemiology, Carlos III Institute of Health, 28029 Madrid, Spain
Nuria Aragonés CIBER Epidemiology and Public Health CIBERESP, 28029 Madrid, Spain; (J.A.-M.); (B.P.-G.); (M.P.); (N.A.); (M.E.-S.); (G.F.-T.); (G.B.); (V.M.); (R.B.-R.); (P.A.); (J.M.H.); (J.A.); (G.C.-V.); (M.K.) Epidemiology Section, Public Health Division, Department of Health of Madrid, 28035 Madrid, Spain
María Ederra-Sanza CIBER Epidemiology and Public Health CIBERESP, 28029 Madrid, Spain; (J.A.-M.); (B.P.-G.); (M.P.); (N.A.); (M.E.-S.); (G.F.-T.); (G.B.); (V.M.); (R.B.-R.); (P.A.); (J.M.H.); (J.A.); (G.C.-V.); (M.K.) Navarra Public Health Institute, 31003 Pamplona, Spain IdiSNA, Navarra Institute for Health Research, 31008 Pamplona, Spain
Guillermo Fernández-Tardón CIBER Epidemiology and Public Health CIBERESP, 28029 Madrid, Spain; (J.A.-M.); (B.P.-G.); (M.P.); (N.A.); (M.E.-S.); (G.F.-T.); (G.B.); (V.M.); (R.B.-R.); (P.A.); (J.M.H.); (J.A.); (G.C.-V.); (M.K.) ISPA (Health Research Institute of the Pincipality of Asturias), IUOPA, University of Oviedo, 33006 Asturias, Spain
Gemma Binefa CIBER Epidemiology and Public Health CIBERESP, 28029 Madrid, Spain; (J.A.-M.); (B.P.-G.); (M.P.); (N.A.); (M.E.-S.); (G.F.-T.); (G.B.); (V.M.); (R.B.-R.); (P.A.); (J.M.H.); (J.A.); (G.C.-V.); (M.K.) Cancer Prevention and Control Program, Catalan Institute of Oncology-IDIBELL, L’Hospitalet de Llobregat, 08901 Barcelona, Spain Department of Clinical Sciences, Faculty of Medicine, University of Barcelona, 08036 Barcelona, Spain
Victor Moreno CIBER Epidemiology and Public Health CIBERESP, 28029 Madrid, Spain; (J.A.-M.); (B.P.-G.); (M.P.); (N.A.); (M.E.-S.); (G.F.-T.); (G.B.); (V.M.); (R.B.-R.); (P.A.); (J.M.H.); (J.A.); (G.C.-V.); (M.K.) Cancer Prevention and Control Program, Catalan Institute of Oncology-IDIBELL, L’Hospitalet de Llobregat, 08901 Barcelona, Spain Department of Clinical Sciences, Faculty of Medicine, University of Barcelona, 08036 Barcelona, Spain
Rocío Barrios-Rodríguez CIBER Epidemiology and Public Health CIBERESP, 28029 Madrid, Spain; (J.A.-M.); (B.P.-G.); (M.P.); (N.A.); (M.E.-S.); (G.F.-T.); (G.B.); (V.M.); (R.B.-R.); (P.A.); (J.M.H.); (J.A.); (G.C.-V.); (M.K.) Departamento de Medicina Preventiva y Salud Pública, Universidad de Granada, 18071 Granada, Spain Instituto de Investigación Biosanitaria ibs, 18012 Granada, Spain
Pilar Amiano CIBER Epidemiology and Public Health CIBERESP, 28029 Madrid, Spain; (J.A.-M.); (B.P.-G.); (M.P.); (N.A.); (M.E.-S.); (G.F.-T.); (G.B.); (V.M.); (R.B.-R.); (P.A.); (J.M.H.); (J.A.); (G.C.-V.); (M.K.) Public Health Division of Gipuzkoa, Biodonostia Research Institute, 20014 San Sebastian, Spain
José María Huerta CIBER Epidemiology and Public Health CIBERESP, 28029 Madrid, Spain; (J.A.-M.); (B.P.-G.); (M.P.); (N.A.); (M.E.-S.); (G.F.-T.); (G.B.); (V.M.); (R.B.-R.); (P.A.); (J.M.H.); (J.A.); (G.C.-V.); (M.K.) Department of Epidemiology, Murcia Regional Health Council, IMIB-Arrixaca, 30120 Murcia, Spain
Enrique Pastor Teso Servicio de Cirugía General y del Aparato Digestivo, Complejo Asistencial Universitario de León, 24008 León, Spain;
Juan Alguacil CIBER Epidemiology and Public Health CIBERESP, 28029 Madrid, Spain; (J.A.-M.); (B.P.-G.); (M.P.); (N.A.); (M.E.-S.); (G.F.-T.); (G.B.); (V.M.); (R.B.-R.); (P.A.); (J.M.H.); (J.A.); (G.C.-V.); (M.K.) Centro de Investigación en Salud y Medio Ambiente (CYSMA), Universidad de Huelva, 21004 Huelva, Spain
Gemma Castaño-Vinyals CIBER Epidemiology and Public Health CIBERESP, 28029 Madrid, Spain; (J.A.-M.); (B.P.-G.); (M.P.); (N.A.); (M.E.-S.); (G.F.-T.); (G.B.); (V.M.); (R.B.-R.); (P.A.); (J.M.H.); (J.A.); (G.C.-V.); (M.K.) Instituto de Salud Global de Barcelona (ISGlobal), 08036 Barcelona, Spain Campus del Mar, Universitat Pompeu Fabra (UPF), 08002 Barcelona, Spain IMIM (Hospital del Mar Medical Research Institute), 08003 Barcelona, Spain
Manolis Kogevinas CIBER Epidemiology and Public Health CIBERESP, 28029 Madrid, Spain; (J.A.-M.); (B.P.-G.); (M.P.); (N.A.); (M.E.-S.); (G.F.-T.); (G.B.); (V.M.); (R.B.-R.); (P.A.); (J.M.H.); (J.A.); (G.C.-V.); (M.K.) Instituto de Salud Global de Barcelona (ISGlobal), 08036 Barcelona, Spain Campus del Mar, Universitat Pompeu Fabra (UPF), 08002 Barcelona, Spain IMIM (Hospital del Mar Medical Research Institute), 08003 Barcelona, Spain
Antonio José Molina de la Torre The Research Group in Gene-Environment and Health Interactions, Institute of Biomedicine (IBIOMED), Universidad de León, 24071 León, Spain; (V.M.-S.); (A.J.M.d.l.T.) Department of Biomedical Sciences, Area of Preventive Medicine and Public Health, Universidad de León, 24071 León, Spain CIBER Epidemiology and Public Health CIBERESP, 28029 Madrid, Spain; (J.A.-M.); (B.P.-G.); (M.P.); (N.A.); (M.E.-S.); (G.F.-T.); (G.B.); (V.M.); (R.B.-R.); (P.A.); (J.M.H.); (J.A.); (G.C.-V.); (M.K.)

Collapse

Eriksen KS, Husebø SIE, Kørner H, Lode K. Long-term Recovery After Colorectal Cancer Surgery Among the Old: A Qualitative Study. Cancer Nurs 2024;47:339-348. [PMID: 37088898 DOI: 10.1097/ncc.0000000000001241] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/25/2023]

Sayer M, Ng DQ, Chan R, Kober K, Chan A. Current evidence supporting associations of DNA methylation measurements with survivorship burdens in cancer survivors: A scoping review. Cancer Med 2024;13:e7470. [PMID: 38963018 PMCID: PMC11222976 DOI: 10.1002/cam4.7470] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/17/2024] [Revised: 05/27/2024] [Accepted: 06/27/2024] [Indexed: 07/05/2024] Open

Abstract

INTRODUCTION

Identifying reliable biomarkers that reflect cancer survivorship symptoms remains a challenge for researchers. DNA methylation (DNAm) measurements reflecting epigenetic changes caused by anti-cancer therapy may provide needed insights. Given lack of consensus describing utilization of DNAm data to predict survivorship issues, a review evaluating the current landscape is warranted.

OBJECTIVE

Provide an overview of current studies examining associations of DNAm with survivorship burdens in cancer survivors.

METHODS

A literature review was conducted including studies if they focused on cohorts of cancer survivors, utilized peripheral blood cell DNAm data, and evaluated the associations of DNAm and survivorship issues.

RESULTS

A total of 22 studies were identified, with majority focused on breast (n = 7) or childhood cancer (n = 9) survivors, and half studies included less than 100 patients (n = 11). Survivorship issues evaluated included those related to neurocognition (n = 5), psychiatric health (n = 3), general wellness (n = 9), chronic conditions (n = 5), and treatment specific toxicities (n = 4). Studies evaluated epigenetic age metrics (n = 10) and DNAm levels at individual CpG sites or regions (n = 12) for their associations with survivorship issues in cancer survivors along with relevant confounding factors. Significant associations of measured DNAm in the peripheral blood samples of cancer survivors and survivorship issues were identified.

DISCUSSION/CONCLUSION

Studies utilizing epigenetic age metrics and differential methylation analysis demonstrated significant associations of DNAm measurements with survivorship burdens. Associations were observed encompassing diverse survivorship outcomes and timeframes relative to anti-cancer therapy initiation. These findings underscore the potential of these measurements as useful biomarkers in survivorship care and research.

Collapse

Zhang S, Chou LN, Swartz MD, Mehta HB, Goodwin JS, Kuo YF, Giordano SH, Tucker CA, Basen-Engquist KM, Lyons EJ, Downer B, Peterson SK, Cao T, Swartz MC. Association of cancer diagnosis with disability status among older survivors of colorectal cancer: a population-based retrospective cohort study. Front Oncol 2024;14:1283252. [PMID: 38559557 PMCID: PMC10978737 DOI: 10.3389/fonc.2024.1283252] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/05/2023] [Accepted: 01/29/2024] [Indexed: 04/04/2024] Open

Abstract

Background

Older cancer survivors likely experience physical function limitations due to cancer and its treatments, leading to disability and early mortality. Existing studies have focused on factors associated with surgical complications and mortality risk rather than factors associated with the development of poor disability status (DS), a proxy measure of poor performance status, in cancer survivors. We aimed to identify factors associated with the development of poor DS among older survivors of colorectal cancer (CRC) and compare poor DS rates to an age-sex-matched, non-cancer cohort.

Methods

This retrospective cohort study utilized administrative data from the Texas Cancer Registry Medicare-linked database. The study cohort consisted of 13,229 survivors of CRC diagnosed between 2005 and 2013 and an age-sex-matched, non-cancer cohort of 13,225 beneficiaries. The primary outcome was poor DS, determined by Davidoff's method, using predictors from 12 months of Medicare claims after cancer diagnosis. Multivariable Cox proportional hazards regression was used to identify risk factors associated with the development of poor DS.

Results

Among the survivors of CRC, 97% were 65 years or older. After a 9-year follow-up, 54% of survivors of CRC developed poor DS. Significant factors associated with future poor DS included: age at diagnosis (hazard ratio [HR] = 3.50 for >80 years old), female sex (HR = 1.50), race/ethnicity (HR = 1.34 for Hispanic and 1.21 for Black), stage at diagnosis (HR = 2.26 for distant metastasis), comorbidity index (HR = 2.18 for >1), and radiation therapy (HR = 1.21). Having cancer (HR = 1.07) was significantly associated with developing poor DS in the pooled cohorts; age and race/ethnicity were also significant factors.

Conclusions

Our findings suggest that a CRC diagnosis is independently associated with a small increase in the risk of developing poor DS after accounting for other known factors. The study identified risk factors for developing poor DS in CRC survivors, including Hispanic and Black race/ethnicity, age, sex, histologic stage, and comorbidities. These findings underscore the importance of consistent physical function assessments, particularly among subsets of older survivors of CRC who are at higher risk of disability, to prevent developing poor DS.

Collapse

Affiliation(s)

Shiming Zhang Department of Biostatistics and Data Science, The University of Texas Health Science Center at Houston School of Public Health, Houston, TX, United States Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States
Lin-Na Chou Department of Biostatistics and Data Science, The University of Texas Medical Branch, Galveston, TX, United States
Michael D. Swartz Department of Biostatistics and Data Science, The University of Texas Health Science Center at Houston School of Public Health, Houston, TX, United States
Hemalkumar B. Mehta Department of Epidemiology, John Hopkins Bloomberg School of Public Health, Baltimore, MD, United States
James S. Goodwin Department of Internal Medicine, The University of Texas Medical Branch, Galveston, TX, United States
Yong-Fang Kuo Department of Biostatistics and Data Science, The University of Texas Medical Branch, Galveston, TX, United States
Sharon Hermes Giordano Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, TX, United States
Carole A. Tucker Department of Physical Therapy, The University of Texas Medical Branch, Galveston, TX, United States
Karen M. Basen-Engquist Department of Health Disparities Research, The University of Texas MD Anderson Cancer Center, Houston, TX, United States
Elizabeth J. Lyons Department of Nutrition, Metabolism and Rehabilitation Sciences, The University of Texas Medical Branch, Galveston, TX, United States
Brian Downer Department of Population Health and Health Disparities, The University of Texas Medical Branch, Galveston, TX, United States
Susan K. Peterson Department of Behavioral Science, The University of Texas MD Anderson Cancer Center, Houston, TX, United States
Tru Cao Department of Biostatistics and Data Science, The University of Texas Health Science Center at Houston School of Public Health, Houston, TX, United States
Maria C. Swartz Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States

Collapse

Schneider J, Hernandez D, Schlander M, Arndt V. Out-of-pocket payments and loss of income among long-term breast cancer survivors in Germany: a multi-regional population-based study. J Cancer Surviv 2023;17:1639-1659. [PMID: 36459378 PMCID: PMC10539192 DOI: 10.1007/s11764-022-01293-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/24/2022] [Accepted: 11/03/2022] [Indexed: 12/03/2022]

Pfister C, Schoenemann J. Selenium in Cancer Rehabilitation-A Retrospective Study from a Specialized Clinic. Nutrients 2023;15:3827. [PMID: 37686861 PMCID: PMC10490249 DOI: 10.3390/nu15173827] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/15/2023] [Revised: 08/31/2023] [Accepted: 08/31/2023] [Indexed: 09/10/2023] Open

Abstract

BACKGROUND

Micronutrient deficiencies are common at the time of cancer diagnosis and are associated with worse prognosis. Little is known about them in cancer rehabilitation.

METHODS

Data from routine health-related quality of life (HRQOL) were analyzed at an inpatient cancer rehabilitation center. Rehabilitation patients completed the EORTC QLQ-C30 questionnaire before and after multidisciplinary rehabilitation treatment and three months after discharge. Selenium and zinc status were measured in whole blood at these three time points. In case of selenium deficiency, up to 600 µg selenium per day as sodium selenite was supplemented for three weeks during and for three months after rehabilitation.

RESULTS

A total of 271 patients (breast, colon, and pancreatic cancer) were included in the analysis. There was clinically meaningful improvement in many domains of the EORTC QLQ-C30 during rehabilitation. However, the effect often waned in the three months after. Prevalence for selenium deficiency varied between 34 to 90% depending on cancer type (breast < colon < pancreas). In contrast, zinc deficiency was rare. Daily selenium supplementation of 600 µg was more efficient to correct selenium deficiency compared to 300 µg selenium per day. Rehabilitation and increasing selenium status after rehabilitation were associated with improved global quality of life, physical and emotional functioning, and fatigue. In cancer patients with decreasing selenium status, values of global quality of life, physical and emotional functioning, and fatigue were back to the values at the beginning of rehabilitation.

CONCLUSIONS

Selenium deficiency is common in cancer patients admitted to a cancer rehabilitation clinic. Selenium supplementation during rehabilitation effectively corrected selenium deficiency in most cases. The positive effects of rehabilitation persisted longer when selenium status did not decrease after rehabilitation.

Collapse

Gonzalez-Mercado VJ, Lim J, Aouizerat B. Insights from Bacterial 16S rRNA Gene into Bacterial Genera and Predicted Metabolic Pathways Associated with Stool Consistency in Rectal Cancer Patients: A Proof of Concept. Biol Res Nurs 2023;25:491-500. [PMID: 36859821 PMCID: PMC10404905 DOI: 10.1177/10998004231159623] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/03/2023]

Thong MSY, Doege D, Weißer L, Koch-Gallenkamp L, Jansen L, Bertram H, Eberle A, Holleczek B, Nennecke A, Waldmann A, Zeissig SR, Brenner H, Arndt V. Persisting Deficits in Health-Related Quality of Life of Colorectal Cancer Survivors 14–24 Years Post-Diagnosis: A Population-Based Study. Curr Oncol 2023;30:3373-3390. [PMID: 36975470 PMCID: PMC10047200 DOI: 10.3390/curroncol30030257] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/06/2023] [Revised: 03/07/2023] [Accepted: 03/10/2023] [Indexed: 03/15/2023] Open

Affiliation(s)

Melissa S. Y. Thong Unit of Cancer Survivorship, Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany Correspondence: ; Tel.: +49-6221-42-2334
Daniela Doege Unit of Cancer Survivorship, Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany
Linda Weißer Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany
Lena Koch-Gallenkamp Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany
Lina Jansen Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany
Heike Bertram Cancer Registry of North Rhine-Westphalia, 44801 Bochum, Germany
Andrea Eberle Bremen Cancer Registry, Leibniz Institute for Prevention Research and Epidemiology—BIPS, 28359 Bremen, Germany
Bernd Holleczek Saarland Cancer Registry, 66024 Saarbrücken, Germany
Alice Nennecke Hamburg Cancer Registry, 20539 Hamburg, Germany
Annika Waldmann Institute for Social Medicine and Epidemiology, University of Lübeck, 23538 Lübeck, Germany
Sylke Ruth Zeissig Institute of Clinical Epidemiology and Biometry (ICE-B), Julius Maximilian University of Würzburg, 97080 Würzburg, Germany Cancer Registry of Rhineland-Palatinate, 55116 Mainz, Germany
Hermann Brenner Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany Division of Preventive Oncology, German Cancer Research Center (DKFZ), National Center for Tumor Diseases (NCT), 69120 Heidelberg, Germany German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany
Volker Arndt Unit of Cancer Survivorship, Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany

Collapse

Eyl-Armbruster RE, Thong MSY, Carr PR, Jansen L, Chang-Claude J, Hoffmeister M, Brenner H, Arndt V. Change Toward Healthier Lifestyles Is Associated With Better Health-Related Quality of Life in Long-Term Colorectal Cancer Survivors. J Natl Compr Canc Netw 2022;20:1233-1243.e10. [PMID: 36351340 DOI: 10.6004/jnccn.2022.7049] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/25/2022] [Accepted: 06/28/2022] [Indexed: 11/11/2022]

Orive M, Anton-Ladislao A, Lázaro S, Gonzalez N, Bare M, Fernandez de Larrea N, Redondo M, Bilbao A, Sarasqueta C, Aguirre U, Quintana JM. Anxiety, depression, health-related quality of life, and mortality among colorectal patients: 5-year follow-up. Support Care Cancer 2022;30:7943-7954. [PMID: 35737143 PMCID: PMC9512719 DOI: 10.1007/s00520-022-07177-1] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/15/2022] [Accepted: 05/25/2022] [Indexed: 10/26/2022]

Abstract

PURPOSE

Health-related quality of life (HRQoL) measurement represents an important outcome in cancer patients. We describe the evolution of HRQoL over a 5-year period in colorectal cancer patients, identifying predictors of change and how they relate to mortality.

METHODS

Prospective observational cohort study including colorectal cancer (CRC) patients having undergone surgery in nineteen public hospitals who were monitored from their diagnosis, intervention and at 1-, 2-, 3-, and 5-year periods thereafter by gathering HRQoL data using the EuroQol-5D-5L (EQ-5D-5L), European Organization for Research and Treatment of Cancer's Quality of Life Questionnaire-Core 30 (EORTC-QLQ-C30), and Hospital Anxiety and Depression Scale (HADS) questionnaires. Multivariable generalized linear mixed models were used.

RESULTS

Predictors of Euroqol-5D-5L (EQ-5D-5L) changes were having worse baseline HRQoL; being female; higher Charlson index score (more comorbidities); complications during admission and 1 month after surgery; having a stoma after surgery; and needing or being in receipt of social support at baseline. For EORTC-QLQ-C30, predictors of changes were worse baseline EORTC-QLQ-C30 score; being female; higher Charlson score; complications during admission and 1 month after admission; receiving adjuvant chemotherapy; and having a family history of CRC. Predictors of changes in HADS anxiety were being female and having received adjuvant chemotherapy. Greater depression was associated with greater baseline depression; being female; higher Charlson score; having complications 1 month after intervention; and having a stoma. A deterioration in all HRQoL questionnaires in the previous year was related to death in the following year.

CONCLUSIONS

These findings should enable preventive follow-up programs to be established for such patients in order to reduce their psychological distress and improve their HRQoL to as great an extent as possible.

CLINICALTRIALS

GOV IDENTIFIER

NCT02488161.

Collapse

Affiliation(s)

Miren Orive Departamento Psicología Social. Facultad Farmacia, UPV/EHU, Vitoria, Spain. .,Red de Investigación en Servicios Sanitarios y Enfermedades Crónicas (REDISSEC), Galdakao, Spain. .,Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud (RICAPPS), Bizkaia, Spain.
Ane Anton-Ladislao Unidad de Investigación, Hospital Galdakao-Usansolo, Galdakao, Bizkaia, Spain.,Red de Investigación en Servicios Sanitarios y Enfermedades Crónicas (REDISSEC), Galdakao, Spain
Santiago Lázaro Servicio de Cirugía General, Hospital Basurto, Bilbao, Bizkaia, Spain.,Red de Investigación en Servicios Sanitarios y Enfermedades Crónicas (REDISSEC), Galdakao, Spain
Nerea Gonzalez Unidad de Investigación, Hospital Galdakao-Usansolo, Galdakao, Bizkaia, Spain.,Red de Investigación en Servicios Sanitarios y Enfermedades Crónicas (REDISSEC), Galdakao, Spain.,Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud (RICAPPS), Bizkaia, Spain
Marisa Bare Unidad de Epidemiología Clínica, Corporacio Parc Tauli, Barcelona, Spain.,Red de Investigación en Servicios Sanitarios y Enfermedades Crónicas (REDISSEC), Galdakao, Spain.,Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud (RICAPPS), Bizkaia, Spain
Nerea Fernandez de Larrea Centro Nacional de Epidemiología, ISCIII, Madrid, Spain.,CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain
Maximino Redondo Unidad de Investigación, Hospital Costa del Sol, Malaga, Spain.,Red de Investigación en Servicios Sanitarios y Enfermedades Crónicas (REDISSEC), Galdakao, Spain.,Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud (RICAPPS), Bizkaia, Spain
Amaia Bilbao Unidad de Investigación, Hospital Basurto, Bilbao, Bizkaia, Spain.,Red de Investigación en Servicios Sanitarios y Enfermedades Crónicas (REDISSEC), Galdakao, Spain.,Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud (RICAPPS), Bizkaia, Spain
Cristina Sarasqueta Unidad de Investigación, Hospital Donostia/BioDonostia, Donostia, Guipuzkoa, Spain.,Red de Investigación en Servicios Sanitarios y Enfermedades Crónicas (REDISSEC), Galdakao, Spain.,Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud (RICAPPS), Bizkaia, Spain
Urko Aguirre Unidad de Investigación, Hospital Galdakao-Usansolo, Galdakao, Bizkaia, Spain.,Red de Investigación en Servicios Sanitarios y Enfermedades Crónicas (REDISSEC), Galdakao, Spain.,Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud (RICAPPS), Bizkaia, Spain
José M Quintana Unidad de Investigación, Hospital Galdakao-Usansolo, Galdakao, Bizkaia, Spain.,Red de Investigación en Servicios Sanitarios y Enfermedades Crónicas (REDISSEC), Galdakao, Spain.,Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud (RICAPPS), Bizkaia, Spain

Collapse

Gibson DC, Raji MA, Holmes HM, Baillargeon JG, Kuo YF. Risk of an Opioid-Related Emergency Department Visit or Hospitalization Among Older Breast, Colorectal, Lung, and Prostate Cancer Survivors. Mayo Clin Proc 2022;97:560-570. [PMID: 35135691 PMCID: PMC8898260 DOI: 10.1016/j.mayocp.2021.08.030] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/05/2021] [Revised: 05/20/2021] [Accepted: 08/26/2021] [Indexed: 12/24/2022]

Benli Yavuz B, Aktan M, Kanyilmaz G, Demir LS. Assessment of Quality of Life Following Radiotherapy in Patients with Rectum Cancer. J Gastrointest Cancer 2022;53:502-510. [DOI: 10.1007/s12029-022-00807-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 01/07/2022] [Indexed: 11/29/2022]

Quality of life, distress, and posttraumatic growth 5 years after colorectal cancer diagnosis according to history of inpatient rehabilitation. J Cancer Res Clin Oncol 2021;148:3015-3028. [PMID: 34874489 PMCID: PMC9508041 DOI: 10.1007/s00432-021-03865-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/22/2021] [Accepted: 11/18/2021] [Indexed: 11/13/2022]

Abstract

Purpose

In Germany, almost every other colorectal cancer (CRC) patient undergoes inpatient cancer rehabilitation (ICR), but research on long-term outcomes is sparse. We aimed to assess health-related quality of life (HRQOL), distress, and posttraumatic growth among former rehabilitants and non-rehabilitants as well as respective differences and to estimate disease-related quality of life deficits in both groups.

Methods

HRQOL (EORTC-QLQ-C30/CR29), distress (QSC-R10), and posttraumatic growth (PTGI) were assessed according to past ICR in patients 5-year post-CRC-diagnosis in the German DACHS study. Least square mean differences in HRQOL scores and elevated distress levels (QSC-R10 > 14 points) by ICR were estimated by confounder-adjusted linear and logistic regression, respectively. Differences in PTGI scales were tested for statistical significance. EORTC-QLQ-C30 reference scores from population controls were accessed from the LinDE study to estimate disease-related deficits in both treatment groups.

Results

49% of the included 1906 CRC survivors had undergone ICR. Rehabilitants reported lower HRQOL scores than non-rehabilitants in several dimensions of the EORTC-QLQ-C30/CR29. Differences were pronounced among younger survivors (< 70 years). In younger survivors, past ICR also predicted elevated distress. However, rehabilitants showed higher posttraumatic growth. When compared to 934 population controls, non-rehabilitants and older rehabilitants reported HRQOL scores (EORTC-QLQ-C30) similar to controls except higher levels of bowel dysfunctions, whereas younger rehabilitants experienced deficits regarding most scales (13/15).

Conclusion

Our findings suggest a high disease burden 5 years after diagnosis in particular among younger CRC survivors who had undergone ICR. Observed HRQOL deficits are possibly linked to the initial indication for ICR and rehabilitants may benefit from effective follow-up concepts after ICR.

Supplementary Information

The online version contains supplementary material available at 10.1007/s00432-021-03865-3.

Collapse

Sawin KJ, Brei TJ, Houtrow AJ. Quality of life: Guidelines for the care of people with spina bifida. J Pediatr Rehabil Med 2021;13:565-582. [PMID: 33325410 PMCID: PMC7838993 DOI: 10.3233/prm-200732] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open

Blackwood J, Rybicki K. Physical function measurement in older long-term cancer survivors. J Frailty Sarcopenia Falls 2021;6:139-146. [PMID: 34557613 PMCID: PMC8419850 DOI: 10.22540/jfsf-06-139] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 04/29/2021] [Indexed: 01/15/2023] Open

Scherer-Trame S, Jansen L, Arndt V, Chang-Claude J, Hoffmeister M, Brenner H. Inpatient rehabilitation therapy among colorectal cancer patients - utilization and association with prognosis: a cohort study. Acta Oncol 2021;60:1000-1010. [PMID: 34137351 DOI: 10.1080/0284186x.2021.1940274] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]

Breidenbach C, Wesselmann S, Sibert NT, Ortmann O, Blankenburg K, Stoklossa C, Gebauer G, Dos Santos Guilherme M, Lindner C, Peschel S, Schad F, Strecker P, Rieger L, Ferencz J, Dieng S, Kowalski C. Use of social service counseling by cancer patients: an analysis of quality assurance data of 6339 breast cancer patients from 13 certified centers in Germany treated between 2015 and 2017. BMC Cancer 2021;21:671. [PMID: 34090379 PMCID: PMC8180094 DOI: 10.1186/s12885-021-08396-1] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/18/2021] [Accepted: 05/23/2021] [Indexed: 11/28/2022] Open

Abstract

Background

Integrated social care may help to mitigate social risk factors in order to achieve more equitable health outcomes. In cancer centers certified according to the criteria set out by the German Cancer Society, every patient must be given low-threshold access to qualified social workers at the center for in-house social service counseling (SSC). Previous analyses have demonstrated large variation in the utilization of these services across individual centers. Therefore, this research aims at investigating whether SSC utilization varies regarding breast cancer patient characteristics and center characteristics presenting a unique approach of using routine data.

Methods

Multilevel modeling was performed using quality assurance data based on 6339 patients treated in 13 certified breast cancer centers in Germany in order to investigate whether SSC utilization varies with patient sex, age, and disease characteristics as well as over time and across centers.

Results

In the sample, 80.3% of the patients used SSC. SSC use varies substantially between centers for the unadjusted model (ICC = 0.24). Use was statistically significantly (P < .001) more likely in women, patients with invasive (in comparison to tumor in situ/ductal carcinoma in situ) diseases (P < .001), patients with both breasts affected (P = .03), patients who received a surgery (P < .001), patients who were diagnosed in 2015 or 2017 compared to 2016 (P < .001) and patients older than 84 years as compared to patients between 55 and 64 years old (P = .002).

Conclusion

The analysis approach allows a unique insight into the reality of cancer care. Sociodemographic and disease-related patient characteristics were identified to explain SSC use to some extent.

Supplementary Information

The online version contains supplementary material available at 10.1186/s12885-021-08396-1.

Collapse

Scherer S, Jansen L, Boakye D, Hoffmeister M, Brenner H. Changes in health-related outcomes among colorectal cancer patients undergoing inpatient rehabilitation therapy: a systematic review of observational and interventional studies. Acta Oncol 2021;60:124-134. [PMID: 33073647 DOI: 10.1080/0284186x.2020.1828620] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]

Abstract

BACKGROUND

Colorectal cancer (CRC) and its treatment can lead to several physical and psychosocial impairments. Cancer rehabilitation aims to reduce morbidity and improve quality of life. The objective of this review was to summarize and evaluate evidence on changes in health-related outcomes among CRC patients undergoing inpatient rehabilitation therapy and on the effectiveness of such treatment.

MATERIAL AND METHODS

We conducted a systematic literature search including the electronic databases Pubmed and Web of Science to find observational and interventional studies, which investigated changes in health-related outcomes among CRC patients undergoing multidisciplinary inpatient rehabilitation programs or treatment effects. Study findings were synthesized narratively.

RESULTS

Eleven studies were eligible and included in this review. Eight patient cohort studies addressed outcomes such as physical and functional status, fecal incontinence, anxiety and depression, and quality of life. Positive changes during rehabilitation therapy were observed for physical health (functional and physical status, fecal incontinence), and several dimensions of quality of life. Study findings concerning anxiety and depression were not conclusive. Studies that additionally conducted long-term follow-ups indicated that the improved health status after rehabilitative treatment waned over time. One RCT reported no effect of inpatient rehabilitation on distress and two randomized trials reported effects of exercise intensity on oxidative stress and immune response. Sample sizes were low (<100 included CRC patients) in eight studies and only the RCT included a comparison group (non-rehabilitants).

CONCLUSION

The scientific evidence level was very limited. Due to the lack of a comparison group in most studies, we were only able to evaluate changes during/after inpatient rehabilitation therapy but not the effectiveness of treatment. However, study findings suggest that physical health and functional independence improve during inpatient rehabilitation, but improvements wane over time. Further large representative studies, in particular RCTs with long-term follow-up, are essential to evaluate the effectiveness of inpatient rehabilitation and identify determinants of treatment success.

Collapse

Mamedov M, Potievskaya V, Saribekyan E, Pikin O, Sidorov D, Salimov Z, Kutsenko V, Drapkina O. Chronic non-communicable diseases, risk factors, and quality of life in patients with malignancies of various localizations. PROFILAKTICHESKAYA MEDITSINA 2021;24:45. [DOI: 10.17116/profmed20212411145] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/10/2024]

Kan JY, Lee YC, Lin YD, Ho WY, Moi SH. Effect of Baseline Characteristics and Tumor Burden on Vaspin Expression and Progressive Disease in Operable Colorectal Cancer. Diagnostics (Basel) 2020;10:diagnostics10100801. [PMID: 33050209 PMCID: PMC7600084 DOI: 10.3390/diagnostics10100801] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/13/2020] [Revised: 09/28/2020] [Accepted: 10/06/2020] [Indexed: 01/11/2023] Open

Firkins J, Hansen L, Driessnack M, Dieckmann N. Quality of life in "chronic" cancer survivors: a meta-analysis. J Cancer Surviv 2020;14:504-517. [PMID: 32162194 DOI: 10.1007/s11764-020-00869-9] [Citation(s) in RCA: 113] [Impact Index Per Article: 22.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/13/2019] [Accepted: 02/18/2020] [Indexed: 12/18/2022]

Abstract

PURPOSE

Cancer survivors are now living longer giving rise to a new concept-chronic cancer as survivors continue to face long-term consequences of cancer and its treatment. For these survivors, QOL becomes a vital consideration in understanding their survivorship and the long-term impact of cancer and its treatment. The primary aim of this review is to describe QOL in cancer survivors two or more years from diagnosis.

METHODS

A meta-analysis was completed of relevant studies assessing QOL in long-term cancer survivorship using PubMed, CINHAL, and PsycINFO. A total of 64 articles met inclusion criteria and included in the analysis. Standardized effect sizes and errors were calculated using previously published standard QOL pass rates to compare QOL across measurement tools and calculate cumulative effect sizes (CES). Fixed-effect or random-effects models were used based on the presence of significant heterogeneity of ≤ 0.10.

RESULTS

Physical health (CES = - 0.894; CI, - 1.472, - 0.316), role-physical health (CES = - 2.039; CI, - 2.643, - 1.435), and mental health (CES = - 0.870; CI, - 1.447, - 0.292) had large, negative cumulative effect sizes signifying worse QOL compared with acceptable QOL rates. Tested moderators, cancer type, average age, country of origin, time since diagnosis, or decade of diagnosis, were not significant to explain heterogeneity between included studies.

CONCLUSION

QOL is significantly impacted 2 to 26 years after cancer diagnosis. More research is needed to determine possible moderators of QOL in long-term cancer survivors.

IMPLICATIONS FOR CANCER SURVIVORS

QOL continues to be significantly impacted in long-term cancer survivorship. More research is needed to understand the impact of these findings on care needs for survivors with chronic cancer.

Collapse

Adam S, Doege D, Koch-Gallenkamp L, Thong MSY, Bertram H, Eberle A, Holleczek B, Pritzkuleit R, Waldeyer-Sauerland M, Waldmann A, Zeissig SR, Jansen L, Rohrmann S, Brenner H, Arndt V. Age-specific health-related quality of life in disease-free long-term prostate cancer survivors versus male population controls-results from a population-based study. Support Care Cancer 2019;28:2875-2885. [PMID: 31736000 DOI: 10.1007/s00520-019-05120-5] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/21/2019] [Accepted: 10/02/2019] [Indexed: 02/07/2023]

Abstract

BACKGROUND

Prostate cancer (PC) and its treatment may affect PC survivors differently with respect to age. However, little is known regarding age-specific health-related quality of life (HRQoL) in PC survivors 5 years or even ≥ 10 years post-diagnosis.

METHODS

The sample included 1975 disease-free PC survivors (5-16 years post-diagnosis) and 661 cancer-free population controls, recruited from two German population-based studies (CAESAR+, LinDe). HRQoL in both populations was assessed using the EORTC QLQ-C30 questionnaire. Additionally, PC survivors completed the PC-specific EORTC QLQ-PR25 questionnaire. Differences in HRQoL between survivors and controls, as well as differences according to age and time since diagnosis were analyzed with multiple regression after adjustment for age, education, stage, and time since diagnosis, where appropriate.

RESULTS

In general, PC survivors reported HRQoL and symptom-burden levels comparable to the general population, except for significantly poorer social functioning and higher burden for diarrhea and constipation. In age-specific analyses, PC survivors up to 69 years indicated poorer global health and social functioning than population controls. Stratification by time since diagnosis revealed little difference between the subgroups. On PC-specific symptoms, burden was highest for urinary bother and symptoms, and lowest for bowel symptoms. Younger age was associated with less urinary symptoms but higher urinary bother.

CONCLUSION

Long-term disease-free PC survivors reported overall good HRQoL, but experienced persistent specific detriments. Our data suggest that these detriments do not improve substantially with increasing time since diagnosis. Targeted interventions are recommended to prevent PC-related and treatment-related symptoms becoming chronic and to enhance social functioning.

Collapse

Affiliation(s)

Salome Adam Unit of Cancer Survivorship, Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.,Division of Chronic Disease Epidemiology, Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Hirschengraben 84, 8001, Zurich, Switzerland
Daniela Doege Division of Chronic Disease Epidemiology, Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Hirschengraben 84, 8001, Zurich, Switzerland
Lena Koch-Gallenkamp Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany
Melissa S Y Thong Division of Chronic Disease Epidemiology, Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Hirschengraben 84, 8001, Zurich, Switzerland
Heike Bertram Cancer Registry of North Rhine-Westphalia, Gesundheitscampus 10, 44801, Bochum, Germany
Andrea Eberle Bremen Cancer Registry, Leibniz Institute for Prevention Research and Epidemiology - BIPS, Achterstraße 30, 28359, Bremen, Germany
Bernd Holleczek Saarland Cancer Registry, Präsident Baltz Straße 5, 66119, Saarbrücken, Germany
Ron Pritzkuleit Schleswig-Holstein Cancer Registry, Ratzeburger Allee 160, 23562, Lübeck, Germany
Mechthild Waldeyer-Sauerland Hamburg Cancer Registry, Billstraße 80, 20539, Hamburg, Germany
Annika Waldmann Hamburg Cancer Registry, Billstraße 80, 20539, Hamburg, Germany.,Institute of Social Medicine and Epidemiology, University Lübeck, Ratzeburger Allee 160, 23562, Lübeck, Germany
Sylke Ruth Zeissig Cancer Registry of Rhineland-Palatinate, Große Bleiche 46, 55116, Mainz, Germany
Lina Jansen Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany
Sabine Rohrmann Division of Chronic Disease Epidemiology, Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Hirschengraben 84, 8001, Zurich, Switzerland
Hermann Brenner Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.,Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.,German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany
Volker Arndt Unit of Cancer Survivorship, Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.

Collapse

Age at Diagnosis and Sex Are Associated With Long-term Deficits in Disease-Specific Health-Related Quality of Life of Survivors of Colon and Rectal Cancer: A Population-Based Study. Dis Colon Rectum 2019;62:1294-1304. [PMID: 31567919 DOI: 10.1097/dcr.0000000000001489] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]

Abstract

BACKGROUND

Despite the increasing number of younger individuals diagnosed with colon and rectal cancer, research on the long-term disease-specific health-related quality of life of younger (<50 years) survivors of colon and rectal cancer is scarce.

OBJECTIVE

Our study aimed to compare disease-specific functional deficits and symptoms of survivors of colon and rectal cancer 5 to 16 years postdiagnosis, stratified by age at diagnosis and by sex.

DESIGN

This is a cross-sectional study.

SETTING

We used data from the population-based CAncEr Survivorship-A multi-Regional study in collaboration with 5 population-based German cancer registries.

PATIENTS

Survivors of colon and rectal cancer were included in the study.

MAIN OUTCOME MEASURES

Respondents completed the disease-specific European Organization for Research and Treatment of Cancer Quality of Life colorectal cancer module. Age at diagnosis categories were <50, 50 to 59, 60 to 69, and ≥70 years. Least square mean health-related quality of life scores, derived from linear regression, were adjusted for sex, education, time since diagnosis, cancer site, cancer stage, and treatment, where appropriate.

RESULTS

The sample comprised 697 survivors of colon cancer and 479 survivors of rectal cancer. In general, survivors of colon and rectal cancer diagnosed at <50 years of age reported lower functioning and higher symptom burden in comparison with survivors diagnosed at an older age. When stratified by sex, female survivors of colon cancer tended to report more concerns with hair loss but fewer sexual problems when compared with male survivors of colon cancer of the same age. Female survivors of rectal cancer in all age groups tended to report lower levels of sexual interest than male survivors of rectal cancer of the same age.

LIMITATIONS

This was a cross-sectional study with findings that could be biased toward healthier long-term survivors. The generalizability of results is limited to survivors diagnosed before 2005.

CONCLUSIONS

Our results suggest that supportive care for survivors of colon and rectal cancer to improve their self-management of symptoms should be adapted according to cancer type, age at diagnosis, and sex. See Video Abstract at http://links.lww.com/DCR/B29. LA EDAD AL DIAGNÓSTICO Y EL GÉNERO ESTÁN ASOCIADOS CON DÉFICITS A LARGO PLAZO EN LA CALIDAD DE VIDA RELACIONADA CON LA SALUD ESPECíFICA DE LA ENFERMEDAD DE LOS SOBREVIVIENTES DE CÁNCER DE COLON Y RECTO: UN ESTUDIO BASADO EN LA POBLACIÓN:: A pesar del creciente número de individuos jóvenes diagnosticados con cáncer de colon y recto, la investigación sobre la calidad de vida relacionada con la salud específica de la enfermedad a largo plazo de los sobrevivientes de cáncer de colon y recto jóvenes (<50 años) es escasa.Nuestro estudio tuvo como objetivo comparar los déficits funcionales específicos de la enfermedad y los síntomas de los sobrevivientes de cáncer de colon y recto 5-16 años después del diagnóstico, estratificados por edad al momento del diagnóstico y por género.Transversal.Utilizamos datos del estudio Supervivencia de CAncEr basada en la población: Un estudio multirregional en colaboración con cinco bases de datos alemanas de cáncer basados en la población.Sobrevivientes de cáncer de colon y recto.Los encuestados respondieron el módulo de calidad de vida específica para la enfermedad en cáncer colorrectal de la Organización Europea para la Investigación y Tratamiento del Cáncer. Las categorías de edad al diagnóstico fueron <50, 50-59, 60-69 y ≥70 años. Los puntajes de CVRS (calidad de vida relacionada a la salud) medios mínimos cuadrados, derivados de la regresión lineal, se ajustaron por género, educación, tiempo desde el diagnóstico, sitio del cáncer, etapa del cáncer y tratamiento, cuando apropiado.La muestra comprendió 697 y 479 sobrevivientes de cáncer de colon y de recto, respectivamente. En general, los sobrevivientes de cáncer de colon y recto diagnosticados con <50 años de edad reportaron una menor funcionalidad y una mayor carga de síntomas en comparación con los sobrevivientes diagnosticados a una edad más avanzada. Cuando se estratificaron por género, las mujeres sobrevivientes de cáncer de colon tendieron a informar más preocupaciones sobre la pérdida de cabello pero menos problemas sexuales en comparación con los hombres sobrevivientes de colon de la misma edad. Las mujeres sobrevivientes de cáncer rectal en todos los grupos de edad tendieron a informar niveles más bajos de interés sexual que los hombres sobrevivientes de cáncer rectal de la misma edad.Estudio transversal con hallazgos que podrían estar sesgados hacia sobrevivientes a largo plazo más saludables. La generalización de los resultados se limitó a los sobrevivientes diagnosticados antes de 2005.Nuestros resultados sugieren que los cuidados de soporte para los sobrevivientes de cáncer de colon y recto para mejorar su automanejo de síntomas deben adaptarse según el tipo de cáncer, la edad en el momento del diagnóstico y el género. Vea el resumen en video en http://links.lww.com/DCR/B29.

Collapse

Dalton SO, Johansen C. European cancer rehabilitation and survivorship, 2018: one of a kind. Acta Oncol 2019;58:519-521. [PMID: 31035842 DOI: 10.1080/0284186x.2019.1606937] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]